Estrogens regulate normal ovarian surface epithelium (OSE) cell functions but also affect epithelial ovarian cancer (OCa) development. Little is known about how estrogens play such opposing roles. Transcriptional profiling using a cDNA microarray containing 2400 named genes identified 155 genes whose expression was altered by estradiol-17b (E2) in three immortalized normal human ovarian surface epithelial (HOSE) cell lines and 315 genes whose expression was affected by the hormone in three established OCa (OVCA) cell lines. All but 19 of the genes in these two sets were different. Among the 19 overlapping genes, five were found to show discordant responses between HOSE and OVCA cell lines. The five genes are those that encode clone 5.1 RNAbinding protein (RNPS1), erythrocyte adducin a subunit (ADD1), plexin A3 (PLXNA3 or the SEX gene), nuclear protein SkiP (SKIIP), and Rap-2 (rap-2). RNPS1, ADD1, rap-2, and SKIIP were upregulated by E2 in HOSE cells but downregulated by estrogen in OVCA cells, whereas PLXNA3 showed the reverse pattern of regulation. The estrogen effects was observed within 6-18 h of treatment. In silicon analyses revealed presence of estrogen response elements in the proximal promoters of all five genes. RNPS1, ADD1, and PLXNA3 were underexpressed in OVCA cell lines compared to HOSE cell lines, while the opposite was true for rap-2 and SKIIP. Functional studies showed that RNPS1 and ADD1 exerted multiple antitumor actions in OVCA cells, while PLXNA3 only inhibited cell invasiveness. In contrast, rap-2 was found to cause significant oncogenic effects in OVCA cells, while SKIIP promotes only anchorageindependent growth. In sum, gene profiling data reveal that (1) E2 exerts different actions on HOSE cells than on OVCA cells by affecting two distinct transcriptomes with few overlapping genes and (2) among the overlapping genes, a set of putative oncogenes/tumor suppressors have been identified due to their differential responses to E2 between the two cell types. These findings may explain the paradoxical roles of estrogens in regulating normal and malignant OSE cell functions.
Introduction
Ovarian cancers (OCas), in particular those arising from the surface epithelium of the ovary, are the deadliest of the gynecologic cancers, with an annual incidence close to 22 220 cases and a death of 16 210 cases (AACR, 2005) . Several theories have been advanced regarding the etiology of epithelial OCa (EOCa), including an imbalance in cell growth and apoptosis brought about by an alteration in the ratio of estrogen to progestin, which is well supported by epidemiological data (Riman et al., 2004) . A decreased incidence of EOCa is observed among ever users of oral contraceptives during their reproductive years. In contrast, among postmenopausal women, the use of hormone replacement therapies (HRTs) has been shown to increase the risk of EOCa in some but not all population-based studies (Garg et al., 1998; Riman et al., 2002; Sit et al., 2002; Bakken et al., 2004) . Furthermore, ever users of estrogen replacement therapy (ERT) are more at risk than ever users of HRT formulations supplemented with progestin (Riman et al., 2002) . Data from a recently completed, large-scale randomized controlled trial, the Women's Health Initiative, corroborate observations in population-based studies (Anderson et al., 2003) .
The best-described action of estrogens related to OCa is stimulation of cell proliferation by physiological concentrations (nanomolar) of the hormones in OCa cells (Nash et al., 1989; Langdon et al., 1990; GaltierDereure et al., 1992; Syed et al., 2001) and in normal ovarian surface epithelial (OSE) cells (Bai et al., 2000; Syed et al., 2001) . Chronic increases in cell replication have been linked to genomic instability (Stopper et al., 2003; Gorringe et al., 2005) , which could be a causative factor of tumor initiation and progression. Conversely, antiestrogens (such as tamoxifen and ICI 182,780), which are effective in inhibiting OCa cell proliferation in cultures (Langdon et al., 1990) , colony formation in soft agar (Runge et al., 1986a, b) , and in vivo growth (Langdon et al., 1993 (Langdon et al., , 1994 , may afford protection against OCa. The action of estrogen is believed to be mediated by the two estrogen receptors (ERs), ER-a and ER-b, which through differential regulation of gene transcription may exert opposite actions on OCa cell growth and survival (Bardin et al., 2004) . Specific genes have been identified to be regulated by estrogens in OCa cells; these include ezrin, a member of the membranecytoskeleton-linking proteins, which controls cell motility and invasion (Song et al., 2005) ; cyclin D1, a regulator of cell cycle progression (Bardin et al., 2004) ; the growth stimulatory cytokine stromal cell-derived factor 1 (SDF-1) (Hall and Korach, 2003) ; transforming growth factor-a (TGF-a) (Simpson et al., 1998) ; and procathepsin D (Galtier-Dereure et al., 1992) . The translational products of these and other estrogenregulated genes may play important roles in the development and/or progression of OCa.
It is now recognized that aberrant transcription of a multitude of genes is involved in the pathogenesis of any human disease, including OCa. For this reason, traditional studies that relied upon the investigation of a few candidate genes at a time may not be the most efficient approach with which to identify novel key molecular regulators governing the process. With the advent of global transcriptional profiling, microarrays that contain thousands of probes are now used as discovery platforms for large-scale identification of gene expression changes associated with a specific physiological state or response to a stimulus. Transcriptional profiling has been used to identify transcriptomes associated with EOCa (Hough et al., 2001; Lee et al., 2004) or different types of EOCas (Welsh et al., 2001; Lancaster et al., 2004) , as well as those that predict clinical outcomes (Lassus et al., 2003; Santin et al., 2004) , responses to chemotherapy, or drug resistance (Sakamoto et al., 2001; Sugimura et al., 2004) . However, this approach has not been utilized to identify genes affected by estrogens in normal or malignant OSE cells.
In this study, a microarray containing 2400 known human genes was used to identify those whose expression was regulated by 17b-estradiol (E2) in three immortalized, nontumorigenic human OSE (HOSE) cell lines and three OCa (OVCA) cell lines. Comparison of these two sets of genes revealed only 19 whose expression is regulated by E2 in HOSE and OVCA cell lines. Among them, five genes were found to be regulated by E2 in HOSE and OVCA cell lines, but in opposite directions. Functional studies demonstrated that they possess antitumorigenic or oncogenic properties to varying degrees. Taken together, these findings led us to postulate that malignant transformation of human OSE cells causes dysregulation of a set of E2-regulated tumor suppressors/oncogenes, a mechanism that may be involved in the observed connection between estrogen exposure and ovarian carcinogenesis in women.
Results
Identification of genes whose expression was regulated by E2 in OVCA cell lines in a manner opposite to that observed in HOSE cell lines
Transcriptional profiling was employed to identify genes whose expression was altered after 5 days of E2 treatment in all three HOSE cell lines or in all three OVCA cell lines based on t-statistics, as described before Ho et al., 2003) . A total of 155 genes were identified as differentially expressed in the HOSE cell lines and 315 genes in the OVCA cell lines after E2 treatment ( Figure 1a) . Among the 155 genes affected by the E2 treatment in HOSE cells, 96 (62%) were upregulated while 59 (38%) were downregulated. In contrast, of the 315 genes whose expression was altered by the E2 treatment in OVCA cell lines, only 72 (23%) were upregulated and 243 (77%) were downregulated. Gene ontogeny analyses revealed that the E2-regulated genes fall into 16 broadly classified functional categories (Figure 1b ). They include categories of genes that encode receptors, transport proteins, binding proteins, tumor suppressors, and oncogenic molecules, as well as those involved in signal transduction, protein modification, apoptosis, protein biosynthesis, transcription processing, cell cycle progression, differentiation, and cell adhesion.
Comparisons were then made to identify genes whose regulation by estrogen was reversed in OVCA cell lines when compared to HOSE cell lines. Among the 19 genes whose expression was altered by E2 in all HOSE and OVCA cell lines, 13 genes were found to be regulated in the same manner by E2 in both HOSE and OVCA cell lines; five were identified as genes upregulated by the hormone treatment, and eight as downregulated (Table 1) . The remaining six genes exhibited discordance with regard to their responses to the E2 treatment between HOSE and OVCA cell lines. Of the six differentially regulated genes, five were upregulated by E2 in HOSE cell cultures and downregulated by the hormone in OVCA cell cultures, while the sixth gene (Sex gene or plexin A3) exhibited an opposite pattern of dysregulation (Table 1) . A literature search of PubMed on April 8, 2005 found no reports linking any one of these genes to estrogen or to OCa. The E2-regulated genes in HOSE and OVCA cell lines were subjected to a web-based service for pathway-mapping analysis. A list of best-matching pathways for HOSE and OVCA cells is illustrated in Table 2 . The genes affected by E2 in both cell types are implicated in vital cellular functions.
Based on the basal expression levels of identified genes in HOSE and OVCA cell lines, we have categorized them into two groups for data presentation: (1) genes encoding clone 5.1 RNA-binding protein (RNPS1), erythrocyte adducin a subunit (ADD1), and Estrogen-regulated genes expression in ovarian cancer cells V Syed et al Expression levels of RNPS1, ADD1, PLXNA3, rap-2, and SKIIP in HOSE and OVCA cell lines and their regulation by estrogen (5 days of treatment)
Lower levels of RNPS1, ADD1, and PLXNA3 transcripts were found in OVCA cell lines compared to HOSE cell lines (Figure 2 ). E2 increased RNPS1 and ADD1 mRNA levels in HOSE cell lines but reduced their levels in OVCA cell lines. In contrast, PLXNA3 expression was downreguated by E2 in HOSE cell lines and upregulated in OVCA cell lines (Figure 2 ). The effects of E2 (5-day treatment) on the expression of these genes were hormone specific, since treatment of HOSE or OVCA cells with ICI, a pure ER antagonist, abolished the E2-induced changes in all cases. Exposure of cell lines to ICI alone induced no effect (Figure 2 ). Basal levels of rap-2, SKIIP, and ACP1 expression were higher in OVCA cell lines compared to HOSE cell lines (Figure 2 ). Significant elevations in rap-2, SKIIP, and ACP1 mRNA levels were observed in HOSE cell lines after exposure to E2, while the levels of these transcripts were reduced in OVCA cell lines by E2 treatment (Figure 2 ). Cotreatment of cell cultures with E2 and ICI reversed the action of the estrogen, whereas the antiestrogen alone exerted no direct effects. RNPS1, ADD1, PLXNA3, rap-2, and SKIIP transcripts are induced in OVCA cell lines by E2 in a time-dependent manner; changes were observed within 6-18 h of exposure To study the time-dependent induction of RNPS1, ADD1, PLXNA3, rap-2, and SKIIP, OVCA cells (OVCA 420 and OVCA 429) were cultured and treated with E2 (10 À6 M) or vehicle for 6, 18, and 36 h. At the termination of culture, cells were collected and RNA was prepared. The decrease in rap-2 transcript was first detected in RNA of OVCA 429 from 6 h of treatment with E2, whereas RNPS1, ADD1, and SKIIP transcripts were significantly decreased and PLXNA3 transcript increased after 18 h of E2 treatment ( Effects of inhibited rap-2 and SKIIP expression in OVCA cell lines
Transcript levels of rap-2 and SKIIP were found to be higher in OVCA cell lines than in HOSE cell lines ( Figure 2a ). Reduction in expression of these genes was achieved by transfection of gene-specific antisense oligodeoxynucleotides (ODNs) at two concentrations (2.5 and 5.0 mM) into individual OVCA cell lines. Significant loss of transcript expression was observed in transfected OVCA cell cultures (Figure 7a ). Reduction in rap-2 expression was associated with inhibition Analysis of promoters of ADD1, RNPS1, SKIIP, Rap-2, and PLXNA3 genes with altered expression after estrogen exposure
Using the Matinspector program (Quandt et al., 1995) , the proximal promoter regions of the five putative estrogen-regulated genes were analysed for the presence of cis-regulatory elements or transcriptional factor (TF)-binding sites that might mediate estrogen action, either directly or through tethering. Results (Table 3) showed that the promoters of all five genes contain estrogen response elements (EREs) or consensus sequence for estrogen receptor-related-a (ERR-a). In addition, TFbinding sites for activator protein-1 (AP-1), specificity protein (Sp-1), and nuclear factor-kB (NF-kB) are commonly found in these genes. In this regard, TFbinding sites for NF-kB and stimulating protein-1 (SP1) are present in the promoters of all five genes whereas AP1 sites were detected in the promoter of three genes.
Discussion
Using transcriptional profiling and stringent data mining criteria, we here identified five genes (RNPS1, ADD1, rap-2, SKIIP, and PLXNA3) whose expression was regulated by E2 in HOSE and OVCA cell lines in opposite directions. These genes have not been reported to be regulated by the hormone in previous studies. Specifically, RNPS1, ADD1, rap-2, and SKIIP are upregulated by E2 in HOSE cells but downregulated by estrogen in OVCA cells, whereas PLXNA3 shows the reverse pattern of regulation by the hormone. RNPS1, ADD1, and PLXNA3 were found to be underexpressed in OVCA cell lines compared to HOSE cell lines. Functional studies showed that RNPS1 and ADD1 exert multiple antitumor actions in OVCA cells, while PLXNA3 inhibits only cell invasiveness. In contrast, rap-2 and SKIIP were found to be overexpressed in OVCA cell lines when compared to HOSE cell lines. Experiments involving antisense-mediated downregulation of rap-2 demonstrated that this gene exerts a broad spectrum of oncogenic effects in OVCA cells, whereas SKIIP promotes only anchorage-independent growth in these cancer cells. Based on these findings, we identify a set of novel E2-regulated genes with tumor suppressive or oncogenic characteristics whose biological roles may have significant relevance to ovarian carcinogenesis and implications for the relationship between ERT/HRT usage and risk of EOCa.
To our knowledge, we are the first to report expression of RNPS1 in human OSE cells and regulation by E2. We observed significant tumor suppressor activity of this gene when it is overexpressed in OCa cells. RNPS1 encodes a protein that functions as a splicing coactivator in the processing of pre-mRNA to mRNA (Badolato et al., 1995; Mayeda et al., 1999) . It also plays a role in mRNA nuclear export and mRNA integrity surveillance (Kim et al., 2001; Lykke-Andersen et al., 2001) . Since proper processing of pre-mRNA and maintenance of postsplicing surveillance are crucial to normal cell function, the loss of RNPS1 expression may disrupt the composition and/or stability of numerous cellular mRNAs, which in turn contribute to tumor growth and progression. Our findings are in agreement with the frequent association between splicing dysregu- Figure 3 Time-dependent E2-induced expression of RNPS1, ADD1, PLXNA3, rap-2, and SKIIP in OVCA cell lines. OVCA cells were treated with E2 (10 À6 M) or vehicle for 6, 18, and 36 h. The time-course studies were conducted twice on separate occasions. The results are the means of two independent experiments. Total RNAs were extracted and analysed for the expression of RNPS1, ADD1, PLXNA3, rap-2, and SKIIP. Two independent RT-PCRs were performed with total RNA of two OVCA cell lines. Relative mRNA levels were expressed as percentage changes after cDNA normalized to those of GAP-DH cDNA. The data are shown as the means7s.d. Statistically significant differences in the transcript levels in estrogen-treated cell lines and those observed in untreated cell cultures at Po0.05 are shown Estrogen-regulated genes expression in ovarian cancer cells V Syed et al lation and malignancy (Faustino and Cooper, 2003) . They are also in concordance with a recent study that demonstrates loss of expression of nmt55/p54 nrb protein, which also has a role in pre-mRNA splicing, in ERnegative breast cancers (Pavao et al., 2001) .
Like RNPS1, the expression of ADD1 was reported and characterized for the first time, in OSE cells. ADD1 encodes a cytoskeleton protein, the adducin a subunit that serves as an obligatory partner for adducin b and g. Adducin a/b and a/g heterodimers oligomerize to form a adducin tetramer complex that mediates interaction between spectrin and actin, which is essential for the maintenance and remodeling of cell membrane skeleton (Matsuoka et al., 2000) . Phosphorylation by protein kinase C or Rho-associated kinase inhibits the activity of adducin, which in turn induces cytoskeleton remodeling and promotes cell motility. Although adducin has been best studied in erythrocytes concerning cell shape and anemia (Birkenmeier and Barker, 2004) , recent investigations have reported its expression in a variety of tissues including brain, muscle, and epithelia (Bennett and Baines, 2001) . A limited number of studies have shown changes in adducin levels and/or phosphorylation during cancer development and the effect on the 0 -CAC TTT GGT GGG CTT AGG AG-3 0 (reverse); for ADD1, 5 0 -GGA ACA AGA TCC GAG AGC AG-3 0 (forward) 5 0 -ACG GTC TGT GAG TGT GGT GA-3 0 (reverse), and plexin A3 mRNA 5 0 -GCT GAG AGG ATC GTG TGT GA-3 0 (forward) and 5 0 -CCT GAG ATG GTA AGC CGT GT-3 0 (reverse). The primers of GAPDH were 5 0 -CATCACCATCTTCCAGGAGC-3 0 (forward) and 5 0 -GGATGATGTTCTGGAGAGCC-3 0 (reverse). The number of PCR cycles used for GAPDH was 25 and for other cDNAs it was 30. All other conditions were the same for PCRs: initial denaturation for 6 min at 941C, cycle denaturation for 1 min at 941C, annealing for 1 min at 601C, and extension at 721C for 1 min. (b) Cell growth was quantified by MTS. The value shown is the percentage growth compared with that of untreated control cells (100%). The data shown represent the mean (7s.d.) of three independent experiments. Statistically significant decreases in gene expression/cell growth compared to that seen in control cells are indicated by *Po0.05
Estrogen-regulated genes expression in ovarian cancer cells V Syed et al motility and metastatic potentials of cancer cells. Specifically, adducin a and b transcripts were found to be upregulated in basal cell carcinoma and squamous cell carcinoma when compared with levels in normal keratinocytes (Bowen et al., 2003) . In contrast, adducin g was found to be downregulated in migrating glioma cells (Mariani et al., 2001) . In renal carcinomas, total adducin levels were decreased, but Ser-660-phosphorylated adducin levels were increased, possibly due to enhanced protein kinase C d activity in these tumors (Fowler et al., 1998) . In the present study, lower levels of ADD1 mRNA were observed in OVCA cells than in HOSE cells. E2 was shown to upregulate ADD1 expression in HOSE cell lines but downregulate its expression in OVCA cells. Since OSE is involved in repeated follicular ruptures and repairs of the follicle wall during reproductive age, a great demand for cytoskeleton remodeling and expression of various adducin subunits are expected in OSE cells. It is also not surprising to find ADD1 expression under E2 regulation, since primary and immortalized OSE cells can convert estrone to E2 and OSE cells are often trapped in the estrogen-rich stroma as inclusion cysts . Our findings that overexpression of ADD1 in OVCA cells is associated with reduced cell proliferation, soft agar The third gene that is underexpressed in OVCA cells when compared with HOSE cells is PLXNA3 or SEX gene. It has been mapped to the chromosome region Xq28 and encodes a transmembrane protein named SEX (Maestrini et al., 1996) . The SEX belongs to the plexin family of proteins, which share a highly conserved cytoplasmic sex-plexin (SP) domain believed to transduce intracellular responses (Tamagnone and Comoglio, 2000) . It is now known that plexins, either alone or through interaction with neuropilins, serve as receptors for semaphorins (Tamagnone and Comoglio, 2000) , a superfamily of over 30 signaling molecules involved in a broad spectrum of normal and aberrant cell functions (Neufeld et al., 2005) . These include axon guidance during nervous system development, regulation of cell migration, antitumorigenic and antiangiogenesis activity, as well as tumor-promoting actions. Specifically, SEX, through interaction with neuropilins, serves as a receptor for semaphorin-3F and possibly for semaphorin-3A (Cheng et al., 2001) . Semaphorins 3B and 3F have potent tumor suppressor activities for small cell lung carcinoma (Roche and Drabkin, 2001 ), an OCa cell line HEY , and a mouse fibrosacroma cell line A9 . In the present study, PLXNA3 was found to be expressed at significant levels in HOSE cell lines and downregulated by E2. These findings suggest participation of SEX, in the environment of declining estrogens after ovulation, in the repair of the ruptured wall of the developing corpus luteum by guiding OSE cell migration. Furthermore, we observed lower levels of PLXNA3 expression in OVCA cell lines and demonstrated suppression of cell invasion when this gene is forced to express. This latter finding is consistent with the postulate that PLXNA3 suppresses metastases for OCa. To our knowledge, this is the first demonstration of expression of PLXNA3 in normal and malignant OSE cells and its regulation by E2. 0 (forward) and 5 0 -TCC TTT GGA ACC AGG TCA GT-3 0 (reverse) primers were used. The GAPDH primers were same as in Figure 5 . The number of PCR cycles used for GAPDH and SKIIP was 25 and for rap-2 cDNAs it was 30. The PCR conditions were initial denaturation for 6 min at 941C, cycle denaturation for 1 min at 941C, annealing for 1 min at 601C, and extension at 721C for 1 min. (b) Cell growth was quantified by MTS assay. The value shown is the percentage growth compared with that of untreated control cells (100%). The data shown represent the mean (7s.d.) of three independent experiments. Statistically significant decreases in gene expression/cell growth compared to those seen in control cells are indicated by *Po0.05
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The rap-2 belongs to the Ras family of small GTPbinding proteins (Campbell et al., 1998) . The protein was first purified from a cytosolic fraction of platelets as a GTP-binding protein of 25 kDa (Nagata et al., 1989) and the gene subsequently cloned with its close relative rap-1 from a cDNA library . It is now known that rap-2 encodes a protein of 183 amino acids with high identity with Rap-1 and K-ras p21 (60 and 46%, respectively) JanoueixLerosey et al., 1992) . The Ras family proteins regulate many cellular processes including proliferation, differentiation, and apoptosis (Campbell et al., 1998) , serving as molecular switches by cycling between the GTPbound active and the GDP-bound inactive form. The GTP-bound forms interact physically with downstream effectors through regions that are highly discriminative in terms of effector recognition. The effector recognition region of Rap-2 differs from those of Ras and Rap-1 by a single amino acid (amino acid 39 in Rap-2 is Phe, while in Ras and Rap-1 it is Ser) and therefore may confer to Rap-2 specific signaling roles distinct from those of Rap-1 and other Ras proteins. It has been reported that Rap-2 activation is important for cell spreading, actin polymerization, enhancement of B-cell adhesion, promotion of integrin activation, and phosphorylation of Pyk2, a tyrosine kinase involved in regulating cell morphology and migration (Jimenez et al., 1991; Lerosey et al., 1991; McLeod et al., 2004) . Rap-1, on the other hand, has been reported to trigger similar but not identical actions, including activation of integrins in T cells and macrophages (Caron et al., 2000; Katagiri et al., 2000; Reedquist et al., 2000) and inhibition of cell adhesion to extracellular matrix proteins (Tsukamoto et al., 1999) . In the present study, Estrogen-regulated genes expression in ovarian cancer cells V Syed et al we observed overexpression of rap-2 in OVCA cells when compared to HOSE cells. Antisense ODNmediated downregulation of rap-2 expression reduced cell growth, colony formation in soft agar, and invasiveness in OVCA cell lines, thus suggesting that rap-2 has potent oncogenic actions in these cell lines. These findings are in marked contrast to our previous observations for rap-1, which is expressed in HOSE and OVCA cells and regulated by the follicular stimulating hormone . Antisense ODN-mediated downregulation of rap-1 in OVCA cells induced no effects on OVCA cell growth, tumorigenicity, and invasiveness . The differential actions of rap-1 and rap-2 in OVCA cells are likely cell-type specific, since Jimenez et al. (1991) reported that rap-1 exerts antagonistic effects on Ras-induced transformation, whereas rap-2 exhibited no such effects.
The last gene that was upregulated in OVCA cells and downregulated in HOSE cells by E2 is SKIIP, which encodes the nuclear Ski interacting protein (SkiP). SkiP is the human homolog of Drosophila melanogaster nuclear protein Bx42 (Folk et al., 1996; Dahl et al., 1998) . Recent evidence suggests that SkiP, like its Drosophila counterpart, plays an important role in transcriptional regulation and is widely expressed in many tissues. It was first described as a nuclear protein that interacted with the oncoprotein v-Ski to mediate its transforming activities (Dahl et al., 1998) . Recent studies demonstrate that SkiP interacts with many transcriptional regulators to modulate transcription. Some of the SkiP partners recently identified include NotchIC (Zhou et al., 2000) , Smad proteins (Leong et al., 2001) , retinoblastoma tumor suppressor (Prathapam et al., 2002) , vitamin D receptor (VDR) (Zhang et al., 2001) , N-CoR/SMRT, and p300 (Leong et al., 2004) . Increased SKIIP expression has been found to enhance gene expression mediated by vitamin D, retinoic acid, estrogen, and glucocorticoid (Baudino 
The promoter regions of the five genes differentially regulated by estrogen in normal (HOSE) and malignant (OVCA) ovarian surface epithelial cells were analysed for the presence of ERE, ER, estrogenrelated receptor (ERR), and other TFs that modulate the estrogen response such as AP1, SP1, or NF-kB using the Matinspector program. Their position to ATG and the strand on which they are present are also indicated. ER: estrogen receptor; ERR, estrogen receptor related; ERE, estrogen respose element; AP1, activator protein 1; SP1, stimulating protein 1; NF-kB, NF-kappaB
Estrogen-regulated genes expression in ovarian cancer cells V Syed et al et al., 1998) . Furthermore, SkiP has been identified as novel binding partner of E7, the major transforming protein of human papillomavirus (Prathapam et al., 2002) . This interaction leads to inhibition of the transcriptional activation activity of SkiP and may promote the transforming activities of E7.
Findings from this study demonstrate overexpression of SKIIP in OVCA cell lines and abrogation of anchorage-independent growth in these OCa cells when SKIIP expression was abrogated by an antisense ODN. These findings are consistent with the notion that SKIIP possesses oncogenic properties in OCa cells. Finally, from a more global perspective, we recognize from our data that OVCA cells differ markedly from HOSE cells in their response to E2. Almost twice as many genes were identified as regulated by estrogen in the OVCA cell lines (315 genes) than in the HOSE cell lines (155 genes). Importantly, E2 primarily downregulated expression of the affected genes in OVCA cell lines (77%) but upregulated the affected genes in HOSE cell lines (62%). An even more striking finding is that only 19 genes were found to be regulated by E2 in both HOSE and OVCA cells; five of them were regulated in opposite directions. A logical explanation is that neoplastic transformation significantly changes the phenotype of the OSE cells and affects their response to this hormone. Under normal conditions, OSE cells are exposed to fluctuating levels of estrogens in the follicular fluid during the reproductive years. Unless the OSE is trapped as inclusion cysts, it is not chronically exposed to high levels of estrogens. After menopause, the OSE is not likely to be stimulated by high levels of estrogens, except in ERT/HRT users. In contrast, it is well documented that OCas produce their own estrogens, sometimes at rather high levels (Heinonen et al., 1982; Taube et al., 2002) . We (Lau et al., 1999) and others (Ho, 2003) have previously reported expression of ER-a and -b in OSE and OCa cells, although the expression of ER-a has been shown to undergo marked reduction in OCa cells when compared to OSE cells. Collectively, these differences may help explain the differential responses of these two cell types to estrogen stimulation at the transcriptional level. In other words, the OSE's response to E2 is intimately linked to the normal physiology of follicular growth and ovulation, whereas OCa cells are under persistent stimulation by estrogens formed de novo in the carcinomas. It is logical to speculate that estrogens regulate very different functions in normal cells than in malignant OSE cells. Of interest, many of the genes affected by E2 in both types of cells are involved in vital cellular functions (Table 2 ) such as phosphoinositide 3 kinase signaling, glycolysis/gluconeogenesis, integrin-mediated cell adhesion, glycerolipid metabolism, purine metabolism, amino-acid metabolism, oxidative phosphorylation, cell cycle, fatty acid metabolism, and pentose phosphate metabolism. However, due to the limited number of probes on the microarrays (2400), we were unable to discern specific gene ontology pathways that are unique to the nontumorigenic or the malignant cell lines after pathway-mapping analyses.
Since the gene profiling was conducted after cell cultures were treated for 5 days with E2, the likelihood that some of the genes are directly regulated by estrogens while others are indirectly modulated by the hormone exists. However, with regard to the five putative E2-regulated genes selected for functional studies, we strongly believed that they are regulated by estrogen in a direct manner. First, the expression for all five genes was found to be altered within the first 6-18 h of estrogen exposure. Secondly, in silicon analyses of their proximal promoters revealed presence of putative EREs or ERR-a sites in all five genes. The other most commonly noted TF-binding sites are NF-kB and SP1, and both have been shown to mediate estrogen action via ER tethering (Chadwick et al., 2005; DeNardo et al., 2005; Ghisletti et al., 2005; Kim et al., 2005) . At present, it is difficult to speculate how estrogen could upregulate a gene in HOSE cells but downregulate its expression in OVCA cells. Alternative utilization of cis-regulatory elements or TF-binding sites may be a mechanism. It is possible that the neoplastic transformation process alters levels of various TFs and hence affects regulation via an direct mechanism such as transactivation via a ERE versus and indirect mechanism through tethering to a different TF. The functional outcomes of these two processes might yield opposite direction of regulation.
In summary, we have demonstrated successful usage of transcriptional profiling, in combination with functional studies, in the discovery of novel, putative tumor suppressors or oncogenes for OCa that are under E2 regulation. Further investigations of the roles of these genes may result in a better understanding of ovarian carcinogenesis and its connection to the risk presented by ERT/HRT usage.
Materials and methods

Cell lines and culture conditions
The HOSE cell lines (HOSE 642, were derived from scrapings of normal/benign ovaries from women with noncancer gynecologic indications and immortalized with human papillomavirus E6 and E7 (Tsao et al., 1995) . The OVCA cell lines (OVCA 429, OVCA 420, and OVCA 432) were established from patients with late-stage serous OCa (Bast et al., 1981) . In our previous publication, we described our use of these cell lines, including the phenotypes and culture conditions (Lau et al., 1999; Syed and Ho, 2003; Syed et al., 2001 Syed et al., , 2002 Syed et al., , 2005 . À6 M E2 for 6, 18, and 36 h before RNA extraction.
RNA isolation, probe preparation and transcriptome comparison
Total RNA was extracted, subjected to quality check, and used in transcriptional profiling with MICROMAXt microarrays (Perkin Elmer, CT), which contain 2400 known human genes, as previously described (Syed et al., 2005) . The Tyramide Signal Amplification (TSA) Labeling and Detection system was used to enhance sensitivity, allowing probe coverage to reach or exceed 80% . The transcriptome in each E2-treated HOSE or OVCA cell line was compared to that of its untreated counterpart on a microarray.
Signal normalization, data processing, and mining of gene of interest Signal normalization, data processing, and gene mining were conducted according to our previously published reports Syed et al., 2005) . Briefly, the fluorescent intensity of each spot was calculated by local median background subtraction. Dye bias and experimental and systematic variations were removed as described before (Yang et al., 2002; Lau et al., 2003) . Log ratios were centered on zero to achieve within-slide normalization and across-slide comparisons. Global medium intensity was used for normalization because it offers the most stability in terms of estimating spatially-dependent and intensity-dependent trends in the log ratios (Yang et al., 2002) . Differentially expressed genes associated with treatment with E2 were then identified by computing the t-values using the two-sample Welch t-statistics method (Callow et al., 2000) and the P-values for each gene for the three HOSE cell lines and separately for the three OVCA cell lines. Genes with an absolute t-value greater than 2 and a P-value o0.05 were identified as differentially expressed due to E2 treatment. To conduct pathway-mapping analyses, all GeneChip entries with a minimum of two-fold absolute changes were submitted to the Database for Annotation, Visualization and Integrated Discovery (DAVID) (Dennis et al., 2003) . Mapped pathways from different transcriptomes were compared visually.
Reverse transcription and quantitative real-time PCR
The estrogen-regulated gene expression pattern was confirmed by real-time PCR. The quantitative real-time PCR reaction was run in iCycler from Bio-Rad (Bio-Rad Laboratories, Hercules, CA, USA) using SybrGreen PCR master mix (Applied Biosystems, Foster City, CA, USA). The primers used for PCR were designed based on the following mRNA sequences from the GenBank: (1) the erythrocyte adducin a subunit mRNA (accession # X58141): 5 0 -TGTCCATGATT CTGCAAAGC-3 0 (forward) 5 0 -GCTGCTGGGTAGACATT TGG-3 0 (reverse); (2) specific cytoplasmic phosphotyrosyl protein phosphatase mRNA (accession # M83653): 5 0 -GCT A CC AAG TCC GTG CTG TT-3 0 (forward) and 5 0 -GAA TGC CGT GCC TCT TCA T-3 0 (reverse); (3) nuclear protein SkiP mRNA (accession # U51432): 5 0 -GACAGCATGACCGGAA TCTT-3 0 (forward) and 5 0 -CCATACCCTTGGATTGGTTG-3 0 (reverse); (4) the SEX gene or plexin A3 mRNA (accession # X87852): 5 0 -CAGCGAGTGCCAGTTTGTAA-3 0 (forward) and 5 0 -CATTGATGATGCTCCAGGTG-3 0 (reverse); (5) clone 5.1 RNA-binding protein mRNA (accession # L37368): 5 0 -GGA GGAGAAACGTGGAGTAGG-3 0 (forward) and 5 0 -GTCCA ACAGCCAGAGAGAGG-3 0 (reverse); (6) the rap-2 mRNA (accession # X12534): 5 0 -GAAGTATCGTCCAGCGAAGG -3 0 (forward) and 5 0 -CATGGGTCATCTTTGTCAGG-3 0 (reverse). For amplification of cDNA of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), the forward primer was 5 0 -ATGTTCGTCATGGGTGTGAA-3 0 and the reverse primer was 5 0 -GTCTTCTGGGTGGCAGTGAT-3 0 . For PCR reaction, 2.5 ml of cDNA derived from reverse transcription of an RNA sample was amplified in a 25 ml reaction mixture containing 12.5 ml of SYBER Green Master Mix and 0.375 ml of 10 mM each primer and 9.25 ml of water.
All samples were amplified in triplicate. Two-step PCR was carried out. After initial denaturation of the samples at 951C for 4 min, 40 cycles of 951C for 30 s, and 601C for 1 min were performed for the generation of all amplimers. A melting curve was run after PCR by increasing temperature from 55 to 951C (0.51C increments). A single peak was obtained for targets, supporting the specificity of the reaction. PCRs for all templates were performed in triplicate in a 96-well plate format, along with positive and negative controls. Relative expression of the real-time RT-PCR products was determined by the WWC t method. The data are represented as means7s.d.
Construction of the clone 5.1 and adducin expression plasmids
Total RNA from a prostate cancer cell line (DU-145) isolated with the TRI reagent (Sigma, St Louis, MO, USA) was reverse transcribed with random hexamers using the GeneAmp RNA PCR kit (Applied Biosystems, Foster City, CA, USA). cDNAs corresponding to the coding sequence of clone 5.1 RNAbinding protein S1 (RNPS1, GenBank accession number NM_006711.2) and erythrocyte adducin a subunit (ADD1, GenBank accession number X87852.1) were amplified with the Platinum Taq DNA polymerase high-fidelity kit (Invitrogen, Carlsbad, CA, USA) using specific forward and reverse primers with BamHI and XbaI recognition sites added to their 5 0 ends, respectively. The forward primer B1-RNF (AGG ATC CGA TTT ATC AGG AGT GAA AAA GAA GA) and reverse primer RNR-Xba (TTC TAG ATT ATC GGG AGG AGT TGG AGC T) were used to amplify RNPS1 CDS, while forward primer B1-ADF (AGG ATC CAA TGG TGA TTC TCG TGC TGC GGT) and reverse primer ADR-Xba (TTC TAG ATC AGG AGT CAC TCT TCT TCT TGC T) were used to amplify erythrocyte adducing-a subunit CDS. The PCR conditions comprised an initiation denaturation at 941C for 2 min followed by 35 cycles of 941C for 20 s, 601C for 30 s, and 681C for 2 min 45 s The last cycle was followed by additional extension incubation of 7 min at 721C. The PCR products were gel-purified by the QIAquick gel extraction kit (Qiagen, Valencia, CA, USA) and TA cloned into pGEM-T easy vector (Promega, Madison, WI, USA) for sequencing. The inserts with the expected sequence were subcloned into pcDNA4/HisMax C at BamHI and XbaI sites and resequenced before large-scale preparation of the plasmid with the EndoFree plasmid Maxi kit (Qiagen).
Transfection of OVCA cells with expression vectors or antisense ODNs
The OVCA cell lines (1 Â 10 5 cells) were transfected with the pSV--galactosidase vector (Promega, Madison, WI, USA) at 1 mg/ml and the expression vector containing a transgene or its respective empty control vectors at 0.5 and 1 mg/ml using LipofectAMINE PLUS (Life Technologies Inc., Rockville, MD, USA) in serum-free medium for 3 h at 371C, followed by incubation with complete medium for 24 h. Some of the transfected cells were stained for X-Gal to estimate transfection efficiency. Transfection efficiencies for OVCA 420, OVCA 429, and OVCA 432 approximated 74, 67, and 68%, respectively. Antisense ODNs (18-mers) phosphorothioate against the human SKIIP and rap-2 mRNAs consisted of the antisense sequences of 5 0 -CATCTTCTACCGCTTCTT-3 0 (AS-SKIIP) and 5 0 -CATCGTCCCTCCGCGGCC-3 0 (AS-rap-2), respectively. The sequences of the mismatched controls for AS-SKIIP and AS-rap-2 were 5 0 -GATCATCAACCGCTACAA-3 0 (AS MM-SKIIP) and 5 0 -GATCGTCGCTGCGCGGGG-3 0 (AS MM-rap-2), respectively. The protocols used for transfection of antisense and mismatched ODNs into OVCA cells for cell proliferation, colony formation, and cell invasion assays were as described previously (Syed et al., 2001 (Syed et al., , 2002 Ho et al., 2003) .
MTS assay
OVCA cells transfected with the expression vector containing a transgene or with an antisense ODN were seeded in 96-well plates, and numbers of cells in cultures were assessed by the MTS assay as described before (Syed et al., 2001; Ho et al., 2003) . Relative cell growth was expressed as fold increases/ decreases over cells transfected with the empty vector or with a mistmatched ODN control.
Soft agar colony formation assay
OVCA cells were transfected with an expression vector containing a transgene or an antisense ODN as previously described (Syed et al., 2005) . After 16-18 h, 10 000 cells were resuspended in 0.35% soft agar and layered on top of 1 ml of 0.6% solidified agar in a 35 mm dish. Soft agar plates seeded with cells transfected with an antisense ODN were treated with antisense every third day. The soft agar colonies were allowed to grow at 371C for 21 days. Colonies were counted under an inverted microscope after 21 days for 2 weeks at weekly intervals.
Cell invasion assay
OVCA cells transfected with an expression vector containing a transgene or an antisense ODN were added to the upper chamber (400 000 cells/well) of a prehydrated polycarbonate membrane filter of 8 mM pore size (Costar, Cambridge, MA, USA) coated with Matrigel (Collaborative Research Inc., MA, USA). The lower chamber was filled with 10% HI-FBS containing complete medium. At 24 h after seeding, cell invasiveness was determined according to the number of cells that had migrated to the reverse side of the filter Syed et al., 2005) .
Promoter analysis by matinspector
The promoter regions of those genes having altered expression following estrogen exposure based on microarray analysis were analysed for the presence of putative ERE/ER-binding sites. Most of the promoter regions analysed had been previously characterized experimentally; however, in some cases, experimentally determined promoters were not available, and 3 kb of the 5 0 regions of the genes of interest was analysed. TF-binding site analyses for ERE/ER were performed using the Matinspector web-based search algorithm available from Genomatix Software (Quandt et al., 1995) . The search algorithm is described in detail at http://www.Genomatix.de.
Statistical analyses
Statistical analyses were carried out using ANOVA, followed by Tukey's post hoc test. Values are presented as mean7s.d. and are considered significant at Po0.05.
